Eda M, Takemoto T, Okada T, Sakashita H, Matzno S, Gohda M, Hayashi K, Nakamura N, Fukaya C
Research Division, Green Cross Corporation, Osaka, Japan.
Chem Pharm Bull (Tokyo). 1996 Feb;44(2):307-13. doi: 10.1248/cpb.44.307.
A series of amino acid conjugates of N-(6-amino-3-pyridyl)-N'-[exo-bicyclo[2.2.1]hept-2-yl]-N''- cyanoguanidine (4) were prepared and evaluated as antihypertensive agents. The parent compound 4 showed potent potassium channel-opening and antihypertensive activities, but with undesirable changes of the urinary balance of electrolytes. However, alanine and histidine congeners (9,19) reduced this undesirable side effect of 4 through improved pharmacokinetics without loss of antihypertensive activity. They also provided additional information on the structural requirements for pinacidil-type potassium channel openers.